Table 4 Analysis of polymorphisms and lung cancer overall survival
From: Polymorphism +17 C/G in Matrix Metalloprotease MMP8 decreases lung cancer risk
MMPs | Genotype | Adjusted* HR [95% CI] | P |
|---|---|---|---|
MMP1 | 1G/1G | Reference | |
1G/2G | 1.25 [0.93–1.69] | 0.143 | |
2G/2G | 1.19 [0.85–1.66] | 0.312 | |
1G + 2G | 1.23 [0.93–1.63] | 0.153 | |
MMP8 | C/C | Reference | |
C/G + G/G | 0.94 [0.68–1.28] | 0.675 | |
MMP13 | A/A | Reference | |
A/G | 0.91 [0.68–1.22] | 0.543 | |
G/G | 1.53 [0.95–2.47] | 0.078 | |
A/G + G/G | 0.97 [0.76–1.23] | 0.803 |